Anticoagulation Patient Self
Testing (INR)

Philips Remote Cardiac Services’ INR@Home Monitoring Service provides the ability for patients to test INR from their home or any other location, eliminating the need to drive to the clinic or laboratory. Self-testing provides a weekly view of INR levels for those on long term anticoagulation therapy.

For Information on Patient Self Testing For INR, Visit www.inrselftest.com

How the Service Works
• Medicare will support weekly testing for patients with Mechanical Heart Valves, Atrial Fibrillation, Deep Venous  
  Thrombosis and Pulmonary Embolism.
• Patients must have been anticoagulated for at least three months prior to enrollment on our service.
• Patients must undergo a face-to-face educational program on anticoagulation management and the use of the INR 
   testing device prior to its use in the home.
• Self-testing with the device is limited to a frequency of once per week.

To access the latest Medicare Coverage Guidelines with expanded indications for INR weekly testing - use the following link.    Revised Guidelines

INR@Home Service 
• Weekly testing helps ensure patients stay in safe, therapeutic range
• Provides timely alerts to doctors when patients are out of range
• Reduces cost of care and improves therapeutic outcomes
• Improves patient satisfaction:
       o Fewer trips to the clinic or lab, which saves time and gasoline.
       o Only a small droplet of blood needed, for less invasive testing.
• Provides greater patient convenience and freedom

For more information on this service, please contact our Customer Service team at 877.729.8350 or
email us at INRinfo@philips.com

To Download Philips Remote Cardiac Services’ INR@Home Brochure, please click here.